Globeflex Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-1,044
| Closed | -$1.1M | – | 492 |
|
2024
Q3 | $1.1M | Hold |
1,044
| – | – | 0.11% | 171 |
|
2024
Q2 | $1.1M | Hold |
1,044
| – | – | 0.11% | 164 |
|
2024
Q1 | $1M | Hold |
1,044
| – | – | 0.1% | 184 |
|
2023
Q4 | $917K | Hold |
1,044
| – | – | 0.09% | 199 |
|
2023
Q3 | $859K | Hold |
1,044
| – | – | 0.1% | 194 |
|
2023
Q2 | $750K | Hold |
1,044
| – | – | 0.08% | 213 |
|
2023
Q1 | $858K | Hold |
1,044
| – | – | 0.1% | 203 |
|
2022
Q4 | $753K | Hold |
1,044
| – | – | 0.1% | 211 |
|
2022
Q3 | $719K | Hold |
1,044
| – | – | 0.12% | 210 |
|
2022
Q2 | $617K | Sell |
1,044
-71
| -6% | -$42K | 0.15% | 194 |
|
2022
Q1 | $779K | Hold |
1,115
| – | – | 0.16% | 179 |
|
2021
Q4 | $704K | Buy |
1,115
+807
| +262% | +$510K | 0.14% | 207 |
|
2021
Q3 | $186K | Buy |
308
+102
| +50% | +$61.6K | 0.04% | 338 |
|
2021
Q2 | $115K | Hold |
206
| – | – | 0.02% | 403 |
|
2021
Q1 | $97K | Buy |
206
+64
| +45% | +$30.1K | 0.02% | 415 |
|
2020
Q4 | $69K | Hold |
142
| – | – | 0.01% | 426 |
|
2020
Q3 | $79K | Buy |
142
+78
| +122% | +$43.4K | 0.02% | 416 |
|
2020
Q2 | $40K | Hold |
64
| – | – | 0.01% | 444 |
|
2020
Q1 | $31K | Buy |
+64
| New | +$31K | 0.01% | 443 |
|